Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance

BACKGROUND: Lymphatic filariasis is targeted for elimination in India through mass drug administration (MDA) with diethylcarbamazine (DEC) combined with albendazole (ABZ). For the strategy to be effective, >65% of those living in endemic areas must be covered by and compliant to MDA. Post the MDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Mohammad A, Sitha, Ashok K, Swain, Subhashisa, Kadam, Shridhar, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166397/
https://www.ncbi.nlm.nih.gov/pubmed/25237478
http://dx.doi.org/10.1186/2049-9957-3-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166397/
https://www.ncbi.nlm.nih.gov/pubmed/25237478
http://dx.doi.org/10.1186/2049-9957-3-31

Ejemplares similares